{
      "Rank": 226,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [
            "Yes"
      ],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "One group of glaucomatous patients will receive 10(6) autologous bone marrow-derived mesenchymal stem cells transplantation into their worst eyes, through an unique intravitreal injections, under anesthesia."
      ],
      "ArmGroupInterventionName": [
            "Procedure: Intravitreal transplantation of mesenchymal stem cell",
            "Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells"
      ],
      "ArmGroupLabel": [
            "MSC transplantion"
      ],
      "ArmGroupType": [
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [
            "<=18 years",
            "Between 18 and 65 years",
            ">=65 years",
            "Female",
            "Male"
      ],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT02330978"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [
            "Brazil"
      ],
      "BaselineDenomCountGroupId": [
            "BG000"
      ],
      "BaselineDenomCountValue": [
            "2"
      ],
      "BaselineDenomUnits": [
            "Participants"
      ],
      "BaselineGroupDescription": [
            "On the thirtieth day after the vitreous injection a combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - promptly treated with a successful pars plana vitrectomy and silicone oil tamponade. At the final follow-up period (12 months), he remained with no retinal detachment and light perception vision."
      ],
      "BaselineGroupId": [
            "BG000"
      ],
      "BaselineGroupTitle": [
            "The First Patient Included at Study"
      ],
      "BaselineMeasureCalculatePct": [
            "No"
      ],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [
            "Count of Participants",
            "Count of Participants",
            "Number"
      ],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [
            "Age, Categorical",
            "Sex: Female, Male",
            "Region of Enrollment"
      ],
      "BaselineMeasureUnitOfMeasure": [
            "Participants",
            "Participants",
            "participants"
      ],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [
            "BG000",
            "BG000",
            "BG000",
            "BG000",
            "BG000",
            "BG000"
      ],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [
            "0",
            "1",
            "1",
            "0",
            "2",
            "2"
      ],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Bone marrow-derived mesenchymal stem cells (MSC) therapy is a promising treatment for several degenerative diseases, including retinopathies and glaucoma, however no previous safety study involving humans has been conducted. The objective of this study is to evaluate effects of autologous bone marrow-derived MSC transplantation in the worst eye of 10 patients with legal bilateral blindness due to glaucoma. Primary outcome are types and severity of adverse effects. Secondary outcomes are changes in visual field, visual acuity, optical coherence tomography, and retinal ganglion cells function."
      ],
      "BriefTitle": [
            "Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma."
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [
            "OTHER_GOV"
      ],
      "CollaboratorName": [
            "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"
      ],
      "CompletionDate": [
            "September 2016"
      ],
      "CompletionDateType": [
            "Actual"
      ],
      "Condition": [
            "Retinal Degeneration",
            "Primary Open-angle Glaucoma"
      ],
      "ConditionAncestorId": [
            "D000009798",
            "D000005128",
            "D000015785",
            "D000012164"
      ],
      "ConditionAncestorTerm": [
            "Ocular Hypertension",
            "Eye Diseases",
            "Eye Diseases, Hereditary",
            "Retinal Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC11",
            "All",
            "BC14",
            "BC16"
      ],
      "ConditionBrowseBranchName": [
            "Eye Diseases",
            "All Conditions",
            "Heart and Blood Diseases",
            "Diseases and Abnormalities at or Before Birth"
      ],
      "ConditionBrowseLeafAsFound": [
            "Glaucoma",
            "Primary Open Angle Glaucoma",
            "Retinal Degeneration"
      ],
      "ConditionBrowseLeafId": [
            "M8165",
            "M8166",
            "M14149",
            "M9176",
            "M11883",
            "M7423",
            "M17491",
            "M14151"
      ],
      "ConditionBrowseLeafName": [
            "Glaucoma",
            "Glaucoma, Open-Angle",
            "Retinal Degeneration",
            "Hypertension",
            "Ocular Hypertension",
            "Eye Diseases",
            "Eye Diseases, Hereditary",
            "Retinal Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000005901",
            "D000005902",
            "D000012162"
      ],
      "ConditionMeshTerm": [
            "Glaucoma",
            "Glaucoma, Open-Angle",
            "Retinal Degeneration"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "N/A"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nDiagnosis of Advanced Bilateral Open-Angle Glaucoma;\nBest corrected visual acuity less than 0,1 in the better eye;\nSocial and cognitive ability to participate.\n\nExclusion Criteria:\n\nSevere systemic morbidities;\nOther ocular blind conditions associated;\nImpossibility in performing any of the proposed examinations."
      ],
      "EnrollmentCount": [
            "2"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [
            "On the thirtieth day after the vitreous injection a combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - promptly treated with a successful pars plana vitrectomy and silicone oil tamponade. At the final follow-up period (12 months), he remained with no retinal detachment and light perception vision."
      ],
      "EventGroupId": [
            "EG000"
      ],
      "EventGroupOtherNumAffected": [
            "0"
      ],
      "EventGroupOtherNumAtRisk": [
            "2"
      ],
      "EventGroupSeriousNumAffected": [
            "1"
      ],
      "EventGroupSeriousNumAtRisk": [
            "2"
      ],
      "EventGroupTitle": [
            "The First Patient Included at Study"
      ],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [
            "0"
      ],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [
            "FG000",
            "FG000",
            "FG000",
            "FG000",
            "FG000",
            "FG000"
      ],
      "FlowAchievementNumSubjects": [
            "1",
            "1",
            "0",
            "1",
            "1",
            "0"
      ],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [
            "One group of glaucomatous patients will receive 10(6) autologous bone marrow-derived mesenchymal stem cells transplantation into their worst eye, through an unique intravitreal injections, under anesthesia.\n\nIntravitreal transplantation of mesenchymal stem cell\n\nCulture and isolation of autologous bone-marrow mesenchymal stem cells"
      ],
      "FlowGroupId": [
            "FG000"
      ],
      "FlowGroupTitle": [
            "MSC Transplantion"
      ],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [
            "STARTED",
            "COMPLETED",
            "NOT COMPLETED",
            "STARTED",
            "COMPLETED",
            "NOT COMPLETED"
      ],
      "FlowPeriodTitle": [
            "The First Patient Included at Study",
            "The Second Patient Included at Study"
      ],
      "FlowPreAssignmentDetails": [
            "The study requisits to enroll patients are too tight and some patients selected do not atend to all admision requisits like vision acuity worse than 20/100 in both eyes, absence of systemic comorbidities, etc."
      ],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "MSC transplantion",
            "MSC transplantion"
      ],
      "InterventionBrowseBranchAbbrev": [
            "CNSDep",
            "All"
      ],
      "InterventionBrowseBranchName": [
            "Central Nervous System Depressants",
            "All Drugs and Chemicals"
      ],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [
            "M3259"
      ],
      "InterventionBrowseLeafName": [
            "Anesthetics"
      ],
      "InterventionBrowseLeafRelevance": [
            "low"
      ],
      "InterventionDescription": [],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Intravitreal transplantation of mesenchymal stem cell",
            "Culture and isolation of autologous bone-marrow mesenchymal stem cells"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Procedure",
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "July 8, 2019"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "April 16, 2019"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "University of Sao Paulo"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Ribeirao Preto"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "Brazil"
      ],
      "LocationFacility": [
            "Ribeir\u00e3o Preto Medical School"
      ],
      "LocationState": [
            "Sao Paulo"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "14049900"
      ],
      "MaximumAge": [
            "90 Years"
      ],
      "MinimumAge": [
            "40 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Intravitreal Autologous Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Advanced Glaucoma. Phase I: Safety Study."
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "University of Sao Paulo"
      ],
      "OrgStudyId": [
            "HCRP 14151/2010"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [
            "OG000"
      ],
      "OutcomeDenomCountValue": [
            "1"
      ],
      "OutcomeDenomUnits": [
            "Participants"
      ],
      "OutcomeGroupDescription": [
            "On the thirtieth day after the vitreous injection a combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - promptly treated with a successful pars plana vitrectomy and silicone oil tamponade. At the final follow-up period (12 months), he remained with no retinal detachment and light perception vision."
      ],
      "OutcomeGroupId": [
            "OG000"
      ],
      "OutcomeGroupTitle": [
            "The First Patient Included at Study"
      ],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [
            "Participants",
            "Participants",
            "Participants",
            "Participants"
      ],
      "OutcomeMeasureDescription": [
            "Retinal detachment"
      ],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [
            "Count of Participants"
      ],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [
            "Posted",
            "Not Posted",
            "Not Posted",
            "Not Posted",
            "Not Posted"
      ],
      "OutcomeMeasureTimeFrame": [
            "6 months",
            "6 months",
            "6 months",
            "6 months",
            "6 months"
      ],
      "OutcomeMeasureTitle": [
            "Type and Severity of Adverse Effects (AE) and Adverse Reactions (AR)",
            "Changes in Visual Acuity",
            "Changes in Visual Field",
            "Changes in Optical Coherence Tomography Parameters Related to Glaucoma",
            "Changes in Retinal Ganglion Cells Function by ERG"
      ],
      "OutcomeMeasureType": [
            "Primary",
            "Secondary",
            "Secondary",
            "Secondary",
            "Secondary"
      ],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [
            "Participants"
      ],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [
            "OG000"
      ],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [
            "1"
      ],
      "OverallOfficialAffiliation": [
            "Associate Professor"
      ],
      "OverallOfficialName": [
            "Jayter S Paula, MD"
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Completed"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1"
      ],
      "PointOfContactEMail": [
            "jspaula@fmrp.usp.br"
      ],
      "PointOfContactOrganization": [
            "University S\u00e3o Paulo"
      ],
      "PointOfContactPhone": [
            "55 16 3602-2499"
      ],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [
            "Jayter Silva de Paula, MD, PhD"
      ],
      "PrimaryCompletionDate": [
            "September 2016"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [
            "Retinal detachment"
      ],
      "PrimaryOutcomeMeasure": [
            "Type and Severity of Adverse Effects (AE) and Adverse Reactions (AR)"
      ],
      "PrimaryOutcomeTimeFrame": [
            "6 months"
      ],
      "ReferenceCitation": [
            "Vilela CAP, Messias A, Calado RT, Siqueira RC, Silva MJL, Covas DT, Paula JS. Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma. Doc Ophthalmol. 2021 Aug;143(1):33-38. doi: 10.1007/s10633-021-09817-z. Epub 2021 Jan 19."
      ],
      "ReferencePMID": [
            "33469852"
      ],
      "ReferenceType": [
            "derived"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "University of Sao Paulo"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "JAYTER SILVA DE PAULA"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "Associate Professor"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [
            "July 8, 2019"
      ],
      "ResultsFirstPostDateType": [
            "Actual"
      ],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [
            "April 16, 2019"
      ],
      "ResultsFirstSubmitQCDate": [
            "April 16, 2019"
      ],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [
            "Changes in Visual Acuity",
            "Changes in Visual Field",
            "Changes in Optical Coherence Tomography Parameters Related to Glaucoma",
            "Changes in Retinal Ganglion Cells Function by ERG"
      ],
      "SecondaryOutcomeTimeFrame": [
            "6 months",
            "6 months",
            "6 months",
            "6 months"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [
            "A combined serous retinal detachment with proliferative vitreoretinopathy was noticed in patient 1 - treated with vitrectomy and silicone oil tamponade. At the final follow-up period he remained with no retinal detachment and light perception vision."
      ],
      "SeriousEventOrganSystem": [
            "Eye disorders"
      ],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [
            "EG000"
      ],
      "SeriousEventStatsNumAffected": [
            "1"
      ],
      "SeriousEventStatsNumAtRisk": [
            "2"
      ],
      "SeriousEventStatsNumEvents": [
            "1"
      ],
      "SeriousEventTerm": [
            "Retinal detachment"
      ],
      "StartDate": [
            "January 2014"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "April 2019"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "January 5, 2015"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "December 31, 2014"
      ],
      "StudyFirstSubmitQCDate": [
            "December 31, 2014"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}